| Name | Title | Contact Details |
|---|
Nobis Rehabilitation Partners brings together hospitals, developers, and investment partners to develop, operate, and manage inpatient rehabilitation facilities (“IRFs”) throughout the United States. With vast experience developing IRFs across the country, the Nobis team has refined both the physical design and operational functionality of the hospital; ultimately streamlining outcomes and profitability.
Polymer Technology Systems, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Indianapolis, IN. To find more information about Polymer Technology Systems, Inc., please visit www.cardiochek.com
Manitoba Institute of Child Health is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Persivia® platform allows IDNs, hospitals, and physician practices to increase revenue, improve quality and succeed under MIPS, CPC+, ACO, OCM and other CMS and commercial value-based payment models.
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.